KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Gross Margin (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Gross Margin data on record, last reported at 72.05% in Q3 2025.

  • For Q3 2025, Gross Margin rose 158.0% year-over-year to 72.05%; the TTM value through Sep 2025 reached 69.31%, down 247.0%, while the annual FY2025 figure was 69.71%, 176.0% down from the prior year.
  • Gross Margin reached 72.05% in Q3 2025 per ZBH's latest filing, up from 71.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 84.19% in Q4 2021 and bottomed at 67.02% in Q2 2021.
  • Average Gross Margin over 5 years is 71.97%, with a median of 71.49% recorded in 2022.
  • The widest YoY moves for Gross Margin: up 430bps in 2022, down -1270bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 84.19% in 2021, then decreased by -15bps to 71.49% in 2022, then rose by 1bps to 72.22% in 2023, then fell by -2bps to 71.0% in 2024, then rose by 1bps to 72.05% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 72.05% in Q3 2025, 71.0% in Q4 2024, and 70.47% in Q3 2024.